- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00581464
Healthier Hearts and Brains in Treating Smoking: The HABITS Study (HABITS)
April 25, 2017 updated by: University of Pittsburgh
80 nicotine dependent adults ages 18-65 who desire to quit smoking will be screened and, if eligible, enrolled and randomized to one of two four-week treatments for smoking cessation.
The treatments are standard behavioral therapy and Mindfulness Based Addiction Therapy (MBAT), which is standard therapy plus mindfulness.
Standard therapy and MBAT incorporate elements of widely-used tools for smoking cessation including managing craving and strong emotions, problem solving, tips on healthy eating and keeping active, and exercises based on cognitive and behavioral therapy.
MBAT uniquely incorporates mindfulness practice (a relaxation therapy) into standard therapy.
Participants complete questionnaires and undergo an fMRI scan at baseline and at the end of therapy (after they complete the 4 weeks of standard therapy or MBAT).
During each scan, participants will complete a validated smoking-related cue paradigm and a validated affect labeling paradigm.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
79
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participants will be considered eligible for enrollment if they are between 18-65 years old, smoke at least ½ pack cigarettes per day, desire to quit smoking (self-reported 75+ out of a possible 100), and have no contraindications for varenicline medication therapy or fMRI scanning (such as body weight over 250 lbs, intravascular metal devices including stents, or claustrophobia).
Exclusion Criteria:
- Participants will not be considered eligible for enrollment if they are not between 18-65 years old, smoke less than ½ pack cigarettes per day, do not desire to quit smoking (self-reported -75 out of a possible 100), or have contraindications for varenicline medication therapy or fMRI scanning (such as body weight over 250 lbs, intravascular metal devices including stents, or claustrophobia).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: 1
|
Standard therapy to help participants with smoking cessation.
|
|
ACTIVE_COMPARATOR: 2
|
A novel mind body therapy that extends basic behavioral therapy principles to include the practice of mindfulness, which fosters a dispassionate approach to the experience of craving.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Smoking Cessation
Time Frame: week 2 and 6 month follow-up
|
week 2 and 6 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Exhaled CO readings
Time Frame: baseline, weeks 2-4, post class follow-up, long term follow-up
|
baseline, weeks 2-4, post class follow-up, long term follow-up
|
|
Saliva Test
Time Frame: baseline
|
baseline
|
|
Functional Magnetic Resonance Imaging
Time Frame: baseline & follow-up
|
baseline & follow-up
|
|
Urine Pregnancy Test
Time Frame: baseline & follow-up
|
baseline & follow-up
|
|
Nicotine Replacement Therapy
Time Frame: Week 1
|
Week 1
|
|
Self Reported Measures
Time Frame: baseline, post class follow-up & long term follow-up
|
baseline, post class follow-up & long term follow-up
|
|
Standard Cognitive Therapy
Time Frame: weeks 1-4
|
weeks 1-4
|
|
Mindfulness Based Cognitive Therapy
Time Frame: weeks 1-4
|
weeks 1-4
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hilary Tindle, MD, University of Pittsburgh
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2009
Primary Completion (ACTUAL)
December 1, 2010
Study Completion (ACTUAL)
December 1, 2010
Study Registration Dates
First Submitted
December 20, 2007
First Submitted That Met QC Criteria
December 26, 2007
First Posted (ESTIMATE)
December 27, 2007
Study Record Updates
Last Update Posted (ACTUAL)
April 27, 2017
Last Update Submitted That Met QC Criteria
April 25, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- PRO08030007
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.